People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Other Health Care, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Particle Dynamics Holdings, Inc. | — | Other Health Care | Series B | $30.9M | $140.6M | 2025 |
| Experic, LLC | — | Other | Series B | $15.0M | $88.5M | 2024 |
| Primrose Bio, Inc. | — | Biotechnology | Series A | $15.0M | $80.3M | 2024 |
Matthew Reber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Reber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Derek Hennecke | 2 | 4 |
| David Wood | 1 | 8 |
| William Mitchell | 1 | 7 |
| J. Todd Mitchell | 1 | 2 |
| Helge Zieler | 1 | 2 |
| Shaun Kirkpatrick | 1 | 2 |
| Michael Caspani | 1 | 2 |
| Matthew Todd Korenberg | 1 | 1 |
| Nicolas Fortin | 1 | 1 |
| Michael Kanan | 1 | 1 |
| Thomas Weller | 1 | 1 |
| Andrew Frazier | 1 | 1 |
| Wes Todd Kaupinen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.